Delivery Order SPE2DB20D3103-SPE2DB24FN2Q4
- Not listed
- This federal contract award is for the delivery of PREMARIN 0.3 MG TABLET 100S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 16, 2025 with a ceiling value of $1,431.06. The contract is a Firm Fixed Price Delivery Order with a completion date of May 19, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen...
- This federal contract award is for the delivery of PREMARIN 0.625 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $1,512.02. The contract is a firm fixed-price Delivery Order with a performance period ending on June 27, 2025. The contract is not set-aside, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the large pharmaceutical distributor Amerisourcebergen Corporation, is for the provision of PREMARIN 0.3 MG TABLET 100S to the Defense Logistics Agency (DLA). The award, valued at $3,572.93, is a firm fixed-price delivery order contract with a completion date of June 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
- This federal contract award is a Delivery Order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of PREMARIN 0.3 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $2,348.42 and a period of performance ending on June 25, 2025. The contract is a Firm Fixed Price contract, with no set-aside designation. Amerisourcebergen Drug Corp is the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract, valued at $1,011.33, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This contract is for the provision of PREMARIN 0.3 MG TABLET 100S, a pharmaceutical product, with a period of performance through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors identified. This delivery order is part of a larger indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Premarin 1.25 mg tablets. The contract has a ceiling value of $1,320.96 and a period of performance ending on September 13, 2024. The contract is a delivery order with a firm fixed price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office division is the prime contractor for this...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PREMARIN 0.3 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $2,900.32 and a period of performance through March 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award is for the delivery of Premarin 0.3mg tablets to the Defense Logistics Agency (DLA), a component of the Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which is a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $2,124.02 and is a firm fixed-price delivery order with a completion date of June 6, 2023. The contract was awarded on June 5, 2023, and there is no set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,362.86, is a delivery order for the supply of PREMARIN 0.3 MG TABLET 100S. This award is not associated with a set-aside program and is a firm fixed-price contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is for the delivery of Premarin 0.3 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA) by the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $5,191.47 and an ultimate completion date of March 8, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which operates as Amerisourcebergen. Both companies...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN2Q4Delivery Order
The federal contract award is for the delivery of PREMARIN 0.3 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,273.50 and a completion date of April 3, 2024. It is a firm fixed-price delivery order contract. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 4/2/24 |